Robert H. Lurie Comprehensive Cancer Center of Northwestern University — Chicago, Illinois

Public research footprint of Robert H. Lurie Comprehensive Cancer Center of Northwestern University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Metastatic Breast Cancer · Lymphoma · Cancer

Recently updated registry entries

NCT05711732 — Busulfan Sample Collection Study (Recruiting)
NCT07015242 — A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line… (Recruiting)
NCT06982521 — Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Robert H. Lurie Comprehensive Cancer Center of Northwestern University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.